MedTrace Logo

Clinical Evaluation of Daily Disposable Etafilcon A Cosmetic Contact Lenses (2022)

NCT05480514 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2024-01-03

Study results available
· View outcomes & findings →

Summary

This is a multi-site, 4-visit, brand-masked, bilateral, 2x2 cross-over dispensing study to evaluate visual acuity.

Conditions

  • Visual Acuity

Interventions

DEVICE

TEST LENS

etafilcon A with cosmetic pattern

DEVICE

CONTROL LENS

Acuvue 1-Day Define Fresh Honey

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Vision Care, Inc. Clinical Trial · Johnson & Johnson Vision Care, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-27
Primary Completion
2022-11-16
Completion
2022-11-16
FDA Device
Yes

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05480514 on ClinicalTrials.gov